AMWA Endorses New Hormone Therapy Statement of Agreement
A Decade after the Women's Health Initiative--the Experts Agree
After 10 years of debate regarding the risks and benefits of hormone therapy, 15 top medical organizations have come together to issue a statement of agreement regarding the benefits of hormone therapy for symptomatic menopausal women. It was July 9, 2002, when the controversial, highly publicized Women’s Health Initiative (WHI) published its assessment of hormone therapy for the prevention of chronic disease and concluded that risks exceeded benefits. The new joint statement, prepared by The North American Menopause Society (NAMS), the American Society for Reproductive Medicine (ASRM), and The Endocrine Society, concludes that hormone therapy is still an acceptable treatment for menopausal symptoms. This statement has been endorsed by 12 other leading organizations in women’s health, including AMWA.
"The American Medical Women's Association Board of Directors unanimously and enthusiastically endorses the July 9, 2012 statement of the North American Menopause Society, the American Society for Reproductive Medicine and the Endocrine Society, which defines the appropriate use of hormone therapy for symptomatic women, based on currently available data. We applaud them for their thoughtful and systematic evaluation of the available data, and their commitment to providing appropriate opinions to American women in this area of expertise."
Read the press release on the solidarity statement.
